244 related articles for article (PubMed ID: 30563988)
21. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
[TBL] [Abstract][Full Text] [Related]
22. New structural variations responsible for Charcot-Marie-Tooth disease: The first two large
Pyromali I; Perani A; Nizou A; Benslimane N; Derouault P; Bourthoumieu S; Fradin M; Sole G; Duval F; Gomes C; Favreau F; Sturtz F; Magdelaine C; Lia AS
Comput Struct Biotechnol J; 2021; 19():4265-4272. PubMed ID: 34429846
[TBL] [Abstract][Full Text] [Related]
23. SV-AUTOPILOT: optimized, automated construction of structural variation discovery and benchmarking pipelines.
Leung WY; Marschall T; Paudel Y; Falquet L; Mei H; Schönhuth A; Maoz Moss TY
BMC Genomics; 2015 Mar; 16(1):238. PubMed ID: 25887570
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
Yao R; Yu T; Qing Y; Wang J; Shen Y
Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
[TBL] [Abstract][Full Text] [Related]
25. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
[TBL] [Abstract][Full Text] [Related]
26. svBreak: A New Approach for the Detection of Structural Variant Breakpoints Based on Convolutional Neural Network.
Wang S; Li J; Haque AKA; Zhao H; Yang L; Yuan X
Biomed Res Int; 2022; 2022():7196040. PubMed ID: 35345526
[TBL] [Abstract][Full Text] [Related]
27. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
[TBL] [Abstract][Full Text] [Related]
28. Free-access copy-number variant detection tools for targeted next-generation sequencing data.
Roca I; González-Castro L; Fernández H; Couce ML; Fernández-Marmiesse A
Mutat Res Rev Mutat Res; 2019; 779():114-125. PubMed ID: 31097148
[TBL] [Abstract][Full Text] [Related]
29. A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.
van den Akker J; Mishne G; Zimmer AD; Zhou AY
BMC Genomics; 2018 Apr; 19(1):263. PubMed ID: 29665779
[TBL] [Abstract][Full Text] [Related]
30. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
[TBL] [Abstract][Full Text] [Related]
31. SCNVSim: somatic copy number variation and structure variation simulator.
Qin M; Liu B; Conroy JM; Morrison CD; Hu Q; Cheng Y; Murakami M; Odunsi AO; Johnson CS; Wei L; Liu S; Wang J
BMC Bioinformatics; 2015 Feb; 16(1):66. PubMed ID: 25886838
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
Steeghs EMP; Kroeze LI; Tops BBJ; van Kempen LC; Ter Elst A; Kastner-van Raaij AWM; Hendriks-Cornelissen SJB; Hermsen MJW; Jansen EAM; Nederlof PM; Schuuring E; Ligtenberg MJL; Eijkelenboom A
BMC Cancer; 2020 Apr; 20(1):291. PubMed ID: 32264863
[TBL] [Abstract][Full Text] [Related]
33. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
34. iSVP: an integrated structural variant calling pipeline from high-throughput sequencing data.
Mimori T; Nariai N; Kojima K; Takahashi M; Ono A; Sato Y; Yamaguchi-Kabata Y; Nagasaki M
BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S8. PubMed ID: 24564972
[TBL] [Abstract][Full Text] [Related]
35. A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically.
Coffee B; Cox HC; Bernhisel R; Manley S; Bowles K; Roa BB; Mancini-DiNardo D
Hum Mutat; 2020 Jan; 41(1):203-211. PubMed ID: 31490007
[TBL] [Abstract][Full Text] [Related]
36. Validation of copy number variation analysis for next-generation sequencing diagnostics.
Ellingford JM; Campbell C; Barton S; Bhaskar S; Gupta S; Taylor RL; Sergouniotis PI; Horn B; Lamb JA; Michaelides M; Webster AR; Newman WG; Panda B; Ramsden SC; Black GC
Eur J Hum Genet; 2017 Jun; 25(6):719-724. PubMed ID: 28378820
[TBL] [Abstract][Full Text] [Related]
37. Next Generation Sequencing in the Clinic: a Patterns of Care Study in a Retrospective Cohort of Subjects Referred to a Genetic Medicine Clinic for Suspected Lynch Syndrome.
Gallego CJ; Perez ML; Burt A; Amendola LM; Shirts BH; Pritchard CC; Hisama FM; Bennett RL; Veenstra DL; Jarvik GP
J Genet Couns; 2016 Jun; 25(3):515-9. PubMed ID: 26637299
[TBL] [Abstract][Full Text] [Related]
38. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
39. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
[TBL] [Abstract][Full Text] [Related]
40. Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on
Surrey LF; Oakley FD; Merker JD; Long TA; Vasalos P; Moncur JT; Kim AS
Arch Pathol Lab Med; 2019 Aug; 143(8):980-984. PubMed ID: 30865489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
